Initiation of trial marks first-in-human milestone for Neomorph's novel molecular glue degrader platform SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company pioneering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results